Precision Radiation Oncology

What Precision Radiation Oncology does

Precision Radiation Oncology is a radiation oncology clinical practice operating under the DBA Precision Radiation Oncology of Rhode Island, providing non-melanoma skin cancer (NMSC) treatment to patients in Rhode Island. The practice's service offering centers on electronic brachytherapy (eBx) delivered through the Axxent system, a proprietary miniaturized 50 kV X-ray source that replicates the dose profile of Ir-192 HDR brachytherapy without radioactive isotopes, allowing treatment in minimally shielded rooms rather than hospital radiation vaults.

The underlying technology platform includes the Axxent Controller, a cooling catheter assembly with a miniaturized X-ray tube, a lightweight (under 150g) surface applicator available in 10/20/35/50 mm sizes, a disposable cooling tubing set, a physics accessories kit, and a vacuum pump. The system delivers 90–95% cure rates for NMSC with an 80–20 penumbral transition under 3 mm (vs. 10–12 mm for MeV electrons), enabling outpatient treatment in dermatology offices and satellite centers.

The business model combines direct clinical service delivery with a partnership integration channel through Advanced Rad Solutions, LLC, which supplies capital, project management, staffing, protocols, training, and coding/billing support to deploy eBx centers within dermatology practices. The dermatology channel is strategic: dermatologists handle 80% of NMSC cases and seek to retain treatment decision-making and revenue that historically leaks to specialty groups, with a sub-12-month practice-level break-even economics cited for adopters.

Name

Precision Radiation Oncology

Legal name

Advanced Rad Solutions, LLC

Website

https://advancedradsolutions.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Precision Radiation Oncology operates a Rhode Island radiation oncology practice delivering non-melanoma skin cancer treatment via the Axxent electronic brachytherapy platform, partnering with Advanced Rad Solutions to integrate minimally shielded, isotope-free X-ray therapy into dermatology and community outpatient settings.

Ownership category

akta.pro rank

Product category

Radiation Therapy Equipment

NAICS

Irradiation Apparatus Manufacturing (334517)

SIC

X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Services-Health Services (8000)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Radiation Therapy Isotopes & Sources (Brachytherapy seeds, sealed sources for oncology) (EUAKAIAD)

Keywords

• Radiation oncology
• Electronic brachytherapy
• Skin cancer treatment
• Radiation therapy devices
• Dermatology equipment

Headquarters

HQ city

Tustin

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Distribution channels1 record

Marketing channels3 records

Core offering

Precision Radiation Oncology delivers radiation oncology services and distributes the Axxent Electronic Brachytherapy (eBx) System, a proprietary miniaturized X-ray platform (50 kV) for non-melanoma skin cancer treatment. The company sells the Axxent eBx system and its accessories to dermatology practices and provides the ARS Skin eBx Center of Excellence integration program that includes project management, capital, staffing, training, and operational support to establish eBx treatment centers. The system eliminates the need for radioactive isotopes and heavily shielded treatment rooms, enabling outpatient procedures in standard examination rooms.

Product overview

Precision Radiation Oncology (through its partner Advanced Rad Solutions) offers the Axxent® Electronic Brachytherapy System (eBx) as its core product platform. This system consists of the Axxent® Controller, Axxent® Miniaturized X-Ray Source (50 kV), Axxent® Cooling Tubing Set, Axxent® Skin Applicator, Axxent® Physics Accessories Kit, and Axxent® Vacuum Pump. The platform enables surface brachytherapy treatment for non-melanoma skin cancer using electronic (non-radioactive) X-ray technology. The Skin Applicators come in four sizes (10mm, 20mm, 35mm, 50mm) to treat areas ranging from 5mm to 45mm in diameter. The company also offers the Skin eBx treatment service and the ARS Skin eBx Center of Excellence program for practices seeking to integrate this therapy into their dermatology offices.

Differentiator

Problem solved

Functional benefit

Products and services

• Axxent Electronic Brachytherapy System (eBx) A leading-edge radiation therapy system that utilizes a proprietary miniaturized X-ray source to apply radiation directly to skin lesions. It delivers high-dose rate, low-energy radiation treatment without the use of radioactive isotopes, enabling treatment in minimally shielded settings.
• Skin eBx Treatment Service
• ARS Skin eBx Center of Excellence Program

Quantifiable outcome

• 90%-95% cure rate for non-melanoma skin cancer without surgery
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Varian Medical Systems (Siemens Healthineers): Varian is the dominant radiation oncology hardware and software provider; its TrueBeam and Ethos platforms compete broadly for NMSC and other radiation therapy cases.
• Accuray: Accuray manufactures CyberKnife and TomoTherapy systems for radiation therapy across multiple indications; competes for radiation oncology budgets at hospitals and large centers.
• Carl Zeiss Meditec: ZEISS offers radiotherapy and intraoperative radiation therapy solutions; it overlaps with the eBx value proposition in delivering targeted radiation in less-shielded settings.
• Elekta: Elekta is a global radiation oncology equipment leader (linear accelerators, brachytherapy afterloaders) — adjacent to ARS in radiation oncology modality, though operating at much larger scale in hospital vaults.
• iCAD (Xoft electronic brachytherapy): iCAD owns the Xoft electronic brachytherapy platform that supplies the Axxent technology underlying ARS's offering; as the OEM/integrator relationship, it is the closest upstream peer in the same device category.

Direct peers

• Sensus Healthcare: Sensus Healthcare develops superficial radiation therapy (SRT) systems such as the SRT-100, directly competing with the Axxent eBx platform in non-melanoma skin cancer treatment within dermatology practices.
• SkinCure Oncology: SkinCure Oncology delivers image-guided superficial radiation therapy (IG-SRT) for NMSC in dermatology offices — the same point-of-care, dermatology-practice channel targeted by Precision Radiation Oncology / ARS.

Others

• Sun Nuclear (Mirion Medical): Sun Nuclear / Mirion provides radiation dosimetry, quality assurance, and physics accessories used alongside brachytherapy and external beam systems — adjacent ecosystem peer in the radiation oncology tool chain.

Emerging players

• ViewRay: ViewRay develops MR-guided radiation therapy systems (MRIdian), an emerging modality in radiation oncology that overlaps with advanced image-guided therapy positioning.
• IntraOp Medical: IntraOp Medical provides intraoperative radiation therapy (IORT) systems using electron-beam and X-ray sources — directly comparable to the miniaturized X-ray source approach used in Axxent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/advanced-rad-solutions-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precision Radiation Oncology